Organization

Royal Brisbane and Women's Hospital, Herston, Australia

2 abstracts

Abstract
Routine, prospective DPYD genotyping guided dose-individualisation for patients receiving fluoropyrimidines: Implementation, prevalence and patient safety outcomes from a multi-institutional clinical trial.
Org: Royal Brisbane and Women’s Hospital and University of Queensland, Brisbane, Australia, Royal Brisbane And Women's Hospital, Brisbane, Australia, Pathology Queensland, Brisbane, Australia, Royal Brisbane and Women's Hospital, Herston, Australia, Royal Brisbane and Women's Hospital, Herston, QLD, Australia,
Abstract
Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic esophageal and gastroesophageal carcinoma with dysphagia: A single arm phase 2 clinical trial, PALEO.
Org: Department of Medical Oncology, Calvary Mater Newcastle, Waratah, Australia, Calvary Mater, Newcastle, Australia, Peter MacCallum Cancer Centre, Melbourne, Australia, Australasian Gastro-Intestinal Trials Group, Sydney, Australia, St. Vincent's Cancer Centre, Fitzroy, Australia,